System, devices, and methods including sterilizing excitation delivery implants with cryptographic logic components

• US 20090163977A1
• Filed: 12/04/2008
• Published: 06/25/2009
• Est. Priority Date: 08/17/2007
• Status: Abandoned Application

• Current Assignee: Searete LLC (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Dacey, Ralph G. JR., Ishikawa, Muriel Y., Smith, Michael A., Myhrvold, Nathan P., Tegreene, Clarence T., Boyden, Edward S., Wood, Lowell L. JR., Rivet, Dennis J., Hyde, Roderick A., Kare, Jordin T., Sweeney, Elizabeth A., Wood, Victoria Y.H., Leuthardt, Eric C., Della Rocca, Gregory J., Santiago, Paul, Stewart, Todd J., Dowling, Joshua L.
• Application Number:
  US12/315,881
• Publication Number:
  US 20090163977A1
• Time in Patent Office: Days
• US Class Current: 607/50
• CPC Class Codes: A61L 2/0011 using physical methods
• CPC Class Codes: A61L 2/08 Radiation

Abstract

Systems, devices, methods, and compositions are described for providing an actively-controllable disinfecting implantable device configured to, for example, treat or prevent an infection in a biological subject.

Claims

1. An implantable device, comprising:

an actively-controllable excitation component configurable to deliver a sterilizing stimulus, in vivo, to tissue proximate an implantable device;

a control means communicatively coupled to the actively-controllable excitation component, the control means configured to control at least one parameter associated with

a sterilizing stimulus delivery regimen, a spaced-apart sterilizing stimulus delivery pattern, a spatial electric field modulation, a spatial electric field magnitude, or a spatial electric field distribution associated with the delivery of the sterilizing stimulus; and

a cryptographic logic component.

2. The implantable device of claim 1, wherein the cryptographic logic component is configured to implement at least one cryptographic process, or cryptographic logic.

3. The implantable device of claim 1, wherein the cryptographic logic component is configured to implement one or more process associated with at least one of a cryptographic protocol, a decryption protocol, an encryption protocol, a regulatory compliance protocol, a regulatory use protocol, an authentication protocol, an authorization protocol, a delivery protocol, an activation protocol, an encryption protocol, or a decryption protocol.

4. The implantable device of claim 1, wherein the cryptographic logic component comprises one or more crypto-algorithms, signal-bearing media, crypto controllers, or cryptographic modules.

5. The implantable device of claim 1, wherein the cryptographic logic component is configured to generate information associated with at least one of an authentication protocol, an authorization protocol, a sterilizing stimulus delivery protocol, an activation protocol, an encryption protocol, or a decryption protocol.

6. The implantable device of claim 1, wherein the cryptographic logic component is configured to generate information associated at least one of an authorization instruction, an authentication instruction, a prescription dosing instruction, a sterilizing stimulus administration instruction, or a prescribed regimen instruction.

7. The implantable device of claim 1, wherein the cryptographic logic component is configured to generate information associated with at least one of an instruction stream, an encrypted data stream, an authentication data stream, or an authorization data stream.

8. The implantable device of claim 1, wherein the cryptographic logic component is configured to generate information associated with at least one of an activation code, an error code, a command code, or an authorization code.

9. The implantable device of claim 1, wherein the cryptographic logic component is configured to generate information associated with at least one of a cryptographic protocol, a decryption protocol, an encryption protocol, a regulatory compliance protocol, or regulatory use protocol.

10. An implantable system, comprising:

circuitry for actively-controlling an excitation component configurable to deliver a sterilizing stimulus, in vivo, to tissue proximate an implantable device; and

circuitry for implementing one or more cryptographic protocols.

11. The implantable system of claim 10, wherein the circuitry for implementing the one or more cryptographic protocols includes circuitry for implementing at least one of a decryption protocol, an encryption protocol, a regulatory compliance protocol, a regulatory use protocol, an authentication protocol, an authorization protocol, a delivery protocol, an activation protocol, an encryption protocol, or a decryption protocol.

12. The implantable system of claim 10, further comprising:

circuitry for obtaining information.

13. The implantable system of claim 10, further comprising:

circuitry for storing the obtained information.

14. The implantable system of claim 10, further comprising:

circuitry for providing information.

15. The implantable system of claim 10, wherein the circuitry for actively-controlling the excitation component is configured to deliver an electrical sterilizing stimulus, in vivo, to tissue proximate an implantable device.